Clinical and Molecular Features of KRAS-Mutated Lung Cancer Patients Treated with Immune Checkpoint Inhibitors.

Autor:	Zhao, Dan1,2 (AUTHOR), Li, Haiqing3,4 (AUTHOR), Mambetsariev, Isa1 (AUTHOR), Mirzapoiazova, Tamara1 (AUTHOR), Chen, Chen4 (AUTHOR), Fricke, Jeremy1 (AUTHOR), Kulkarni, Prakash1 (AUTHOR), Villaflor, Victoria1 (AUTHOR), Arvanitis, Leonidas5 (AUTHOR), Hamilton, Stanley5 (AUTHOR), Afkhami, Michelle5 (AUTHOR), Pillai, Raju5 (AUTHOR), Armstrong, Brian6 (AUTHOR), Erhunmwunsee, Loretta7 (AUTHOR), Massarelli, Erminia1 (AUTHOR), Sattler, Martin8,9 (AUTHOR), Amini, Arya10 (AUTHOR), Salgia, Ravi1 (AUTHOR) rsalgia@coh.org
Zdroj:	Cancers. Oct2022, Vol. 14 Issue 19, p4933. 12p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu